Harvard Medical Journal Calls Chronic Inflammation the Silent Killer

Indeed, inflammation has been identified by scientists and medical professionals as a starting point for many other diseases including cancers, strokes, and heart disease. In fact, it was recently reported that those afflicted with viruses like COVID-19 showed more severe symptoms if they were already dealing with inflammation issues. 

It’s also why major pharmaceutical and biotech companies like Pfizer (NYSE:PFE), AbbVie (NYSE:ABBV), and Amgen (NASDAQ:AMGN) are all doing extensive research into inflammation. Treatments are far and few between, and while certain aspects can be controlled by diet and lifestyle, medications are necessary to deal with the more severe cases. 

Another company to add to your watchlist is Ludwig Enterprises (OTC:LUDG). The company recently announced a specific focus on chronic inflammation and have acquired several massive databases of patient data to run analysis on. The company has established an artificial intelligence division to analyze this data, in hopes of honing in on a way to develop a treatment for this debilitating issue. 

Featured: $PFE $ABBV $AMGN $LUDG


Stay Connected
Latest News
From Sponsor
PubCo Insight. Deep Intelligence
Including AI Reports
for Savvy Investors

If you’re looking for a way to get an edge on the stock market, you need to check out PubCo Insight. Using AI, our system is able to make highly accurate stock picks that can help you achieve major gains. With our AI Reports, you’ll be able to learn which stocks are the most traded, undervalued, and have the most potential for growth. This valuable information is absolutely essential for anyone who wants to be successful in the stock market. So sign up now and get started on your path to success!

%d bloggers like this: